Blanket Purchase Agreement 36F79720D0099-36E79720A0007

The federal contract IDV award is a Blanket Purchase Agreement (BPA) between the U.S. Department of Veterans Affairs (VA) and Otsuka America Pharmaceutical Inc., a pharmaceutical manufacturer. The $15 million BPA, awarded in March 2020, is specifically for the delivery of Jynarque (tolvaptan), a medication used to treat autosomal dominant polycystic kidney disease and hyponatremia in VA patients. This BPA, along with a $396 million Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs schedule, facilitates the efficient ordering of Otsuka's pharmaceutical products by VA medical facilities and integrated service networks across the country. The majority of task orders issued under these IDVs are for the delivery of Jynarque, although they also allow for the procurement of other Otsuka medications as needed. The task orders reviewed, valued between $10,000 and $113,000, are firm fixed price contracts with no set-aside designations, reflecting Otsuka's status as a large pharmaceutical manufacturer. These task orders specify delivery locations in various VA regions, including Pittsburgh, Pennsylvania and Chelsea, Maine, to support the VA's healthcare services for veterans.